Xgenomes Corp.
Cambridge, MA
- UEI
- URQZNV343D65
- CAGE
- 9VBZ3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 750 Main St, Cambridge, MA 02139, USA
- Website
- xgenomes.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i gravity-independent single-molecule multi-omic sequencing | Shared Services Center | $224,937 | |
| Sttr phase i gravity-independent single-molecule multi-omic sequencing | Shared Services Center | $224,923 | |
| Achieving ultra-high-density, ultra-high-precision single molecule localization microscopy with whole-video deep… | National Institute of General Medical Sciences | $349,280 | |
| A novel ctdna analysis solution for the next-generation of liquid biopsy assays - project summary/abstract detection and… | National Cancer Institute | $399,816 | |
| Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding… | National Human Genome Research Institute | $795,198 |
About Xgenomes Corp.
Xgenomes Corp. is a minority-owned, for-profit corporate entity registered in SAM.gov, located in Cambridge, MA, that specializes in advanced biotechnology and genomic research technologies. The company focuses on developing cutting-edge molecular analysis platforms that leverage machine learning, super-resolution microscopy, and innovative DNA sequencing techniques to address critical challenges in medical research and diagnostics. Through its technological innovations, Xgenomes aims to create transformative solutions for genomic analysis, particularly in areas such as cancer research, epigenetic modification detection, and high-precision molecular imaging.
The company has secured multiple federal grant awards from prestigious scientific agencies, including the National Institute of General Medical Sciences, National Cancer Institute, and National Human Genome Research Institute. These project grants, ranging from $349,280 to $399,816, support the development of sophisticated technologies such as ultra-high-density single molecule localization microscopy (SMLM), novel circulating tumor DNA (ctDNA) analysis platforms, and advanced epigenetic modification sequencing methods. Specific research objectives include creating machine learning algorithms for SMLM video analysis, developing DNA analysis platforms that can directly measure genetic mutations and methylation changes, and designing super-resolution single-molecule sequencing technologies that can read short sequence "words" with unprecedented accuracy. The research aims to significantly advance medical diagnostics, particularly in cancer research, by creating more precise and comprehensive molecular analysis techniques that can be made available to the academic research community.
Quick answers
What is Xgenomes Corp.'s UEI?
Xgenomes Corp.'s Unique Entity ID (UEI) in SAM.gov is URQZNV343D65.
What is Xgenomes Corp.'s CAGE code?
Xgenomes Corp.'s CAGE code is 9VBZ3.
What is Xgenomes Corp.'s primary NAICS code?
Xgenomes Corp.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Xgenomes Corp. located?
Xgenomes Corp.'s physical address in SAM.gov is 750 Main St, Cambridge, MA 02139, USA.
Is Xgenomes Corp. registered in SAM.gov?
Yes. Xgenomes Corp.'s SAM.gov registration is active through August 22, 2027.
What is Xgenomes Corp.'s most recent federal award?
Xgenomes Corp.'s most recent federal contract award is Sbir phase i gravity-independent single-molecule multi-omic sequencing (80NSSC26C0372), from Shared Services Center, on September 30, 2026.
On GovTribe
See Xgenomes Corp.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors